Cole G Bradley

CIK 00013377984 companiesLONDON

SEC Profile

Transactions

Companies

Filings

CIK

0001337798

Recent Transactions

50 trades

Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-07-29$81.43/sh−3,673→ 11,672 total
Gift
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-07-29−4,500→ 7,172 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-05-29+12,158→ 12,158 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2026-05-29+2,026→ 2,026 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-05-29+2,799→ 15,345 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2026-05-29−2,799→ 0 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2026-05-28+11,766→ 11,766 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2026-05-22+13,667→ 32,976 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2026-05-22−13,667→ 0 total
Sale
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2026-03-05$28.51/sh−2,655→ 19,309 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Stock option (right to buy)
2026-03-05−4,748→ 20,000 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2026-03-05$3.38/sh+4,748→ 26,712 total
Sale
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2026-03-05$28.44/sh−4,748→ 21,964 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2025-05-22+13,667→ 13,667 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2025-05-21+8,673→ 21,964 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2025-05-21−8,673→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 9,373 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2024-05-25+8,636→ 13,291 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2024-05-25−8,636→ 0 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2024-05-23+8,673→ 8,673 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2023-06-29+5,000→ 5,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2023-06-02−3,825→ 0 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2023-06-02+3,825→ 4,655 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2023-05-25+8,636→ 8,636 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-06-29+30,000→ 30,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2022-06-29+5,000→ 5,000 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Common Stock
2022-06-10+830→ 830 total
Exercise/Conversion
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2022-06-10−830→ 0 total
Award
CASTLE BIOSCIENCES INC$CSTL
Stock option (right to buy)
2022-06-02+7,647→ 7,647 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2022-06-02+3,825→ 3,825 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2021-06-29+33,237→ 33,237 total
Award
CASTLE BIOSCIENCES INC$CSTL
Restricted Stock Units
2021-06-10+830→ 830 total
Award
CASTLE BIOSCIENCES INC$CSTL
Stock option (right to buy)
2021-06-10+3,379→ 3,379 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2020-07-27+37,965→ 37,965 total
Award
CASTLE BIOSCIENCES INC$CSTL
Stock option (right to buy)
2020-06-04+8,000→ 8,000 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Stock Option (right to buy)
2020-02-19−13,422→ 0 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Stock Option (right to buy)
2020-02-19−3,934→ 0 total
Sale
EXACT SCIENCES CORP$EXAS
Common Stock
2020-02-19$100.00/sh−27,356→ 10,194 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Common Stock
2020-02-19$35.91/sh+13,422→ 37,550 total
Exercise/Conversion
EXACT SCIENCES CORP$EXAS
Common Stock
2020-02-19$35.28/sh+3,934→ 24,128 total

Companies

Recent Filings

Address

C/O KINIKSA PHARMACEUTICALS INT'L 105 PICCADILLY, SECOND FLOOR

LONDON, W1J 7NJ

View on SEC.gov